perfosfamide has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ascensao, JL; Cardoso, AA; Fallon, M; Gaffney, J; Marusic, M; Mukherji, B; Silva, MR | 1 |
| Gross, MA; Moreb, J; Weiner, RS; Zucali, JR | 1 |
2 other study(ies) available for perfosfamide and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Effect of pharmacological purging on natural killer cell number and activity in human bone marrow.
Topics: Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cyclophosphamide; Cytotoxicity, Immunologic; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Leukocyte Count; Tumor Cells, Cultured | 1992 |
Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.
Topics: Adult; Bone Marrow; Cell Differentiation; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Interleukin-1; Leukemia, Erythroblastic, Acute | 1989 |